Octapharma is one of the largest human protein product manufacturers in the world. Our core business is the development, production and sale of premium human proteins from human plasma and human cell-lines. Octapharma employs over 5,000 people in 28 countries with sales of approximately €1 billion per annum. Patients in over 100 countries are treated with products in the following therapeutic areas:
Hematology (coagulation disorders)
Immunotherapy (immune disorders)
Intensive Care and Emergency Medicine
Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico.
For more information please visit www.octapharma.com.